These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 26744442)
1. Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas. Liu TT; Achrol AS; Mitchell LA; Du WA; Loya JJ; Rodriguez SA; Feroze A; Westbroek EM; Yeom KW; Stuart JM; Chang SD; Harsh GR; Rubin DL AJNR Am J Neuroradiol; 2016 Apr; 37(4):621-8. PubMed ID: 26744442 [TBL] [Abstract][Full Text] [Related]
2. Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes. Li HY; Sun CR; He M; Yin LC; Du HG; Zhang JM World Neurosurg; 2018 Apr; 112():e407-e414. PubMed ID: 29355809 [TBL] [Abstract][Full Text] [Related]
3. Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma. Bilello M; Akbari H; Da X; Pisapia JM; Mohan S; Wolf RL; O'Rourke DM; Martinez-Lage M; Davatzikos C Neuroimage Clin; 2016; 12():34-40. PubMed ID: 27358767 [TBL] [Abstract][Full Text] [Related]
4. Probabilistic radiographic atlas of glioblastoma phenotypes. Ellingson BM; Lai A; Harris RJ; Selfridge JM; Yong WH; Das K; Pope WB; Nghiemphu PL; Vinters HV; Liau LM; Mischel PS; Cloughesy TF AJNR Am J Neuroradiol; 2013 Mar; 34(3):533-40. PubMed ID: 22997168 [TBL] [Abstract][Full Text] [Related]
5. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370 [TBL] [Abstract][Full Text] [Related]
6. MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication. Zhou J; Reddy MV; Wilson BKJ; Blair DA; Taha A; Frampton CM; Eiholzer RA; Gan PYC; Ziad F; Thotathil Z; Kirs S; Hung NA; Royds JA; Slatter TL AJNR Am J Neuroradiol; 2018 Feb; 39(2):252-259. PubMed ID: 29191871 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images. Cui Y; Tha KK; Terasaka S; Yamaguchi S; Wang J; Kudo K; Xing L; Shirato H; Li R Radiology; 2016 Feb; 278(2):546-53. PubMed ID: 26348233 [TBL] [Abstract][Full Text] [Related]
9. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator. Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236 [TBL] [Abstract][Full Text] [Related]
10. Impact of removed tumor volume and location on patient outcome in glioblastoma. Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405 [TBL] [Abstract][Full Text] [Related]
11. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066 [TBL] [Abstract][Full Text] [Related]
12. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma. van Dijken BRJ; Jan van Laar P; Li C; Yan JL; Boonzaier NR; Price SJ; ; van der Hoorn A J Neurosurg; 2018 Oct; 131(3):717-723. PubMed ID: 30485234 [TBL] [Abstract][Full Text] [Related]
13. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma. Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702 [TBL] [Abstract][Full Text] [Related]
14. Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen. Nelson SJ; Kadambi AK; Park I; Li Y; Crane J; Olson M; Molinaro A; Roy R; Butowski N; Cha S; Chang S Neuro Oncol; 2017 Mar; 19(3):430-439. PubMed ID: 27576874 [TBL] [Abstract][Full Text] [Related]
15. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation. Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493 [TBL] [Abstract][Full Text] [Related]
16. Age groups related glioblastoma study based on radiomics approach. Li Z; Wang Y; Yu J; Guo Y; Zhang Q Comput Assist Surg (Abingdon); 2017 Dec; 22(sup1):18-25. PubMed ID: 28914549 [TBL] [Abstract][Full Text] [Related]
17. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients. Chaddad A; Sabri S; Niazi T; Abdulkarim B Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951 [TBL] [Abstract][Full Text] [Related]
18. Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth. Toh CH; Castillo M AJNR Am J Neuroradiol; 2017 Feb; 38(2):288-293. PubMed ID: 27856439 [TBL] [Abstract][Full Text] [Related]
19. Relationship between Glioblastoma Heterogeneity and Survival Time: An MR Imaging Texture Analysis. Liu Y; Xu X; Yin L; Zhang X; Li L; Lu H AJNR Am J Neuroradiol; 2017 Sep; 38(9):1695-1701. PubMed ID: 28663266 [TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme. Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]